• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Celanese Corp (NY: CE )

    138.05 -1.08 (-0.78%)
    Official Closing Price Updated: 4:10 PM EDT, Jun 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 814,980
    Open 138.47
    Bid (Size) 129.30 (1)
    Ask (Size) 150.00 (1)
    Prev. Close 139.13
    Today's Range 137.84 - 139.32
    52wk Range 105.15 - 172.16
    Shares Outstanding 110,830,000
    Dividend Yield 2.03%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    A Closer Look at 13 Analyst Recommendations For Celanese
    Via Benzinga
    7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
    Here are seven Warren Buffett stocks to sell that the Oracle himself has decided that they've lost their luster. 
    Via InvestorPlace

    Performance

    YTD
    -10.77%
    -10.77%
    1 Month
    -11.81%
    -11.81%
    3 Month
    -16.56%
    -16.56%
    6 Month
    -8.69%
    -8.69%
    1 Year
    +26.86%
    +26.86%

    More News

    Read More
    AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Celanese Corporation Declares Force Majeure on Western Hemisphere Acetic Acid and VAM
    From Celanese Corporation
    Via Business Wire
    The Analyst Verdict: Celanese In The Eyes Of 11 Experts
    Via Benzinga
    How Is The Market Feeling About Celanese?
    Via Benzinga
    A Closer Look at 11 Analyst Recommendations For Celanese
    Via Benzinga
    $1000 Invested In Celanese 15 Years Ago Would Be Worth This Much Today
    Via Benzinga
    China Strikes Back At Biden's Tariffs With New Investigation Into Plastics Imports: 6 Stocks Caught In Crossfire
    Via Benzinga
    Topics World Trade
    Exposures Tariff
    Celanese To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Celanese Receives American Chemistry Council’s 2024 Sustainability Leadership Award for Achievements in Circularity
    From Celanese Corporation
    Via Business Wire
    CE Stock Earnings: Celanese Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    9 Analysts Assess Celanese: What You Need To Know
    Via Benzinga
    Here's How Much $1000 Invested In Celanese 15 Years Ago Would Be Worth Today
    Via Benzinga
    How Is The Market Feeling About Celanese?
    Via Benzinga
    Celanese Corporation Reports First Quarter Earnings
    From Celanese Corporation
    Via Business Wire
    3 Must-Own Stocks to Scoop Up if You Have $500 to Invest
    Via InvestorPlace
    Celanese Announces Kim K.W. Rucker as New Lead Independent Director
    From Celanese Corporation
    Via Business Wire
    Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024
    From Celanese Corporation
    Via Business Wire
    Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
    From Celanese Corporation
    Via Business Wire
    Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention
    From Celanese Corporation
    Via Business Wire
    Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain
    From Celanese Corporation
    Via Business Wire
    Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol
    From Celanese Corporation
    Via Business Wire
    Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
    From Celanese Corporation
    Via Business Wire
    Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.